| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/28/2008 | WO2007150015A3 Method of treatment |
| 02/28/2008 | WO2007150001A8 Pyrro[1,2-b]pyridazinone compounds |
| 02/28/2008 | WO2007149030A8 Novel heteroaryl substituted benzoxazoles |
| 02/28/2008 | WO2007147575A3 Substituted sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprisings same, methods of preparing same and uses same |
| 02/28/2008 | WO2007147125A3 Tetracycline package formulations |
| 02/28/2008 | WO2007146900A3 Antihypertensive therapy method |
| 02/28/2008 | WO2007146139A3 Codon-optimized dna molecules encoding the receptor binding domains of clostridium difficile toxins a and b |
| 02/28/2008 | WO2007144668A3 Process for the preparation of s-fluoromethyl-6, 9 -difluoro-11 -hydroxy-16 -methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates |
| 02/28/2008 | WO2007143006A3 Polymeric biosurfactants |
| 02/28/2008 | WO2007141593A3 Process for the preparation of metoprolol and its salts |
| 02/28/2008 | WO2007140000A3 Administration of the reg1 anticoagulation system |
| 02/28/2008 | WO2007139967A3 Triazole compounds that modulate hsp90 activity |
| 02/28/2008 | WO2007139729A8 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase |
| 02/28/2008 | WO2007138282A3 Bi-aryl or aryl-heteroaryl substituted indoles |
| 02/28/2008 | WO2007137167A3 Co-therapy for the treatment of epilepsy |
| 02/28/2008 | WO2007136592A3 2-0x0-l,2-dihydr0quin0line derivatives, compositions, and uses thereof as antiproliferative agents |
| 02/28/2008 | WO2007133572A3 Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure |
| 02/28/2008 | WO2007127263A3 Therapeutic uses of urolithins |
| 02/28/2008 | WO2007120730A3 Fused ring thrombin receptor antagonists |
| 02/28/2008 | WO2007120270A3 Glucagon receptor antagonists, preparation and therapeutic uses |
| 02/28/2008 | WO2007119110A3 Process for the preparation of tamsulosin and related compounds |
| 02/28/2008 | WO2007117581A3 Stabilized transdermal bupropion preparations |
| 02/28/2008 | WO2007113857A3 Modified release clopidogrel formulation |
| 02/28/2008 | WO2007109357A3 Controlled release formulation of tolterodine |
| 02/28/2008 | WO2007104034A3 Glucokinase activators |
| 02/28/2008 | WO2007103290A3 Materials and methods directed to asparagine synthetase and asparaginase therapies |
| 02/28/2008 | WO2007097888A3 Fluoroquinolone carboxylic acid salt compositions |
| 02/28/2008 | WO2007090617A3 Thiadiazole derivatives for the treatment of neuro degenerative diseases |
| 02/28/2008 | WO2007089673A3 Compositions and methods for treatment of ophthalmic diseases and disorders |
| 02/28/2008 | WO2007087667A3 Combination preparation for improving sperm quality |
| 02/28/2008 | WO2007084670A8 Specific therapy using integrin ligands for treating cancer |
| 02/28/2008 | WO2007076055A3 Compositions and methods comprising proteinase activated receptor antagonists |
| 02/28/2008 | WO2007070494A3 Heterocycles and derivatives thereof and methods of manufacture and therapeutic use |
| 02/28/2008 | WO2007064846A3 COMPOSITIONS AND METHODS OF USING siRNA TO KNOCKDOWN GENE EXPRESSION AND TO IMPROVE SOLID ORGAN AND CELL TRANSPLANTATION |
| 02/28/2008 | WO2007054904A3 Macrolides as anti-inflammatory agents |
| 02/28/2008 | WO2007054836A3 1, 2-substituted naphthalene derivatives with antiglutamatergic properties and uses thereof |
| 02/28/2008 | WO2007052289B1 Novel dispersible tablet composition |
| 02/28/2008 | WO2007037874B1 Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear |
| 02/28/2008 | WO2007033366A8 Biphenyl-pyrazolecarboxamide compounds |
| 02/28/2008 | WO2007033348A3 Process for the synthesis of rocuronium bromide |
| 02/28/2008 | WO2007025043A3 Seven-membered ring nucleosides |
| 02/28/2008 | WO2007022459A3 Processes and intermediates |
| 02/28/2008 | WO2007017510A3 Isophthalic acid diamides for treating alzheimer's disease |
| 02/28/2008 | WO2007016095A3 Cyclooxygenase-2 selective inhibitor compounds comprising nitric oxide enhancing groups, compositions and methods of use |
| 02/28/2008 | WO2006138466A3 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules |
| 02/28/2008 | WO2006119260A3 Combination of dipeptidyl peptidase-iv inhibitor and a cannabinoid cb1 receptor antagonist for the treatment of diabetes and obesity |
| 02/28/2008 | WO2004100860A3 Stable liposomes for microencapsulation of animal venoms |
| 02/28/2008 | WO2000040692A3 Methods and compositions for delivering nucleic acids |
| 02/28/2008 | US20080051905 Supplemental spine fixation device and method |
| 02/28/2008 | US20080051904 Supplemental spine fixation device and method |
| 02/28/2008 | US20080051785 Spine distraction implant and method |
| 02/28/2008 | US20080051702 Therapeutic agent delivery for the treatment of asthma via implantable and insertable medical devices |
| 02/28/2008 | US20080051691 Implantable shunt or catheter enabling gradual delivery of therapeutic agents |
| 02/28/2008 | US20080051690 Combination Therapy for Preventing or Treating Alzheimer's Disease, and Kit Therefor |
| 02/28/2008 | US20080051577 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/28/2008 | US20080051561 Residual solvent extraction method and microparticles produced thereby |
| 02/28/2008 | US20080051490 Medical Devices and Applications of Polyhydroxyalkanoate Polymers |
| 02/28/2008 | US20080051466 Isoalpha acid based protein kinase modulation cancer treatment |
| 02/28/2008 | US20080051465 Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment |
| 02/28/2008 | US20080051464 Protein phosphatase inhibitors |
| 02/28/2008 | US20080051463 Anthracene compounds and their use for treating benign and malignant tumor disorders |
| 02/28/2008 | US20080051462 Methods for treating genetically-defined proliferative disorders with HSP90 inhibitors |
| 02/28/2008 | US20080051461 Peeling process based on surfactants and acids |
| 02/28/2008 | US20080051460 Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| 02/28/2008 | US20080051459 Long term 24-hour intestinal administration of levodopa/carbidopa |
| 02/28/2008 | US20080051458 Acyloxyalkyl carbamate prodrugs of alpha-amino acids, methods of synthesis and use |
| 02/28/2008 | US20080051456 Glycine Reuptake Inhibitors for Treatment of Drug Dependence |
| 02/28/2008 | US20080051454 Compositions and methods for transient receptor potential vanilloid (TRPV) channel mediated treatments |
| 02/28/2008 | US20080051453 Sorbic acid analog co-crystals |
| 02/28/2008 | US20080051452 Hexanoic acid derivatives as dipeptidyl peptidase inhibitors |
| 02/28/2008 | US20080051451 Autoimmune conditions and NADPH oxidase defects |
| 02/28/2008 | US20080051450 Process For The Preparation Of Anhydrous And Hydrated Active Pharmaceutical Ingredients (Apis); Stable Pharmaceutical Compositions Prepared From The Same And Uses Of Said Compositions |
| 02/28/2008 | US20080051449 Preparation of atorvastatin calcium form vi and compositions thereof |
| 02/28/2008 | US20080051448 Stabilized extended release pharmaceutical compositions comprising an amg-coa reductase inhibitor |
| 02/28/2008 | US20080051447 Treatment Of Hypercholesterolemia, Hypertriglyceridemia And Cardiovascular-Related Conditions Using Phospholipase-A2 Inhibitors |
| 02/28/2008 | US20080051445 2-Thioxothiazolidin-4-one compounds and compositions as antimicrobial and antimalarial agents targeting enoyl-ACP reductase of type II fatty acid synthesis pathway and other cell growth pathways |
| 02/28/2008 | US20080051444 Compounds for the reduction of excessive food intake |
| 02/28/2008 | US20080051443 Compounds for the reduction of excessive food intake |
| 02/28/2008 | US20080051442 Agent for prevention and treatment of cancer comprising oxadiazole urea compound obstructing activity of stat |
| 02/28/2008 | US20080051441 Aryl Sulphonamide Modulators |
| 02/28/2008 | US20080051440 Compositions for weight management |
| 02/28/2008 | US20080051439 Methods of food intake management |
| 02/28/2008 | US20080051438 Preventive/Therapeutic Compositions Useful for Treating Cardiovascular Diseases |
| 02/28/2008 | US20080051437 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
| 02/28/2008 | US20080051436 Use of Acylaminothiazole Derivatives as Therapeutic Agents |
| 02/28/2008 | US20080051435 Crystalline and amorphous forms of tiagabine |
| 02/28/2008 | US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 02/28/2008 | US20080051433 Pyrrole-3-Carboxamide Derivatives for the Treatment of Obesity |
| 02/28/2008 | US20080051432 Piperidine-2, 6-dione derivatives and their use as tumor necrosis factor inhibitors |
| 02/28/2008 | US20080051431 Methods and compositions using immunomodulatory compounds in combination therapy |
| 02/28/2008 | US20080051430 Dietetics; antidiabetic agents; sexual disorders |
| 02/28/2008 | US20080051429 Use of 4-amino-piperidines for treating sleep disorders |
| 02/28/2008 | US20080051428 Pyrroloquinoline quinone drugs and methods of use thereof |
| 02/28/2008 | US20080051427 Pharmaceutical Compositions and Methods of Using Same |
| 02/28/2008 | US20080051426 9-fluoro-3,3,6-trimethyl-2,3,4,7-tetrahydroindolo[2,3-c]quinolin-1-one; reacting substituted 1-oxo-2,3,4,7-tetrahydro-1H-5-oxonia-7-azabenzo[c]fluorene perchlorates, dihydrophosphates or tetrafluoroborates with ammonium hydroxide or ammonium acetate; ischemia-reperfusion injury; antidepressant |
| 02/28/2008 | US20080051425 Vinorelbine derivatives |
| 02/28/2008 | US20080051424 Heterocyclyl-substituted nonadepsipeptides |
| 02/28/2008 | US20080051423 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/28/2008 | US20080051422 4-Aminoquinazoline derivatives and methods of use thereof |
| 02/28/2008 | US20080051421 pyrazolo- and imidazo-pyrimidine derivatives; for anxiety and pain, neurodegenerative disorders; 8-Pyridin-4-yl-4-trifluoromethyl-2-(4-trifluoromethyl-phenyl)-imidazo[1,5-a]pyrimidine |